Our Resources | Association for Accessible Medicines

AAM All Access Podcast - Featuring AAM CEO Dan Leonard and Apotex President and CEO Jeff Watson

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

Jul 13, 2021 | Erica Klinger

New Evidence Shows Medicare Part D Plans Continue to Fail to Get New Generics to Seniors

AAM Patients - Voices of Access

May 24, 2021 | Erica Klinger

AAM Voices of Access

Roadmaps for Ensuring Patient Access to Generic and Biosimilar Medicines: Securing Sustainable Markets

Feb 22, 2021 | Erica Klinger

Roadmaps for Ensuring Patient Access to Generic and Biosimilar Medicines: Securing Sustainable Markets

Potential Savings from Accelerating US Approval of Complex Generics

Feb 9, 2021 | Erica Klinger

White Paper: Potential Savings from Accelerating U.S. Approval of Complex Generics

Nitrosamines: An Industry Position Paper Based on Risk

Oct 6, 2020 | Erica Klinger

White Paper: Nitrosamines — An Industry Position Paper Based on Risk

2020 Generic Drug and Biosimilars Access & Savings in the U.S. Report - Cover image

Sep 29, 2020 | Erica Klinger

2020 Generic Drug & Biosimilars Access and Savings in the U.S. Report

AAM Blueprint Supply Chain Header

Apr 30, 2020 | Erica Klinger

A Blueprint for Enhancing the Security of the U.S. Pharmaceutical Supply Chain

Feb 20, 2020 | Craig Burton

White Paper: Medicare and Commercial Plans Fail to Get New Generics to Patients

Jan 23, 2020 | Craig Burton

White Paper: Sidelined: How Seniors Miss Out On Savings Available Through Generic Substitution

Jan 1, 2020 | Erica Klinger

The Unintended Economics of the BLOCKING Act

Sep 20, 2019 | Craig Burton

White Paper: Access Denied: Why New Generics Are Not Reaching America's Seniors

Sep 18, 2019 | Erica Klinger

Report: 2019 Generic Drug & Biosimilars Access & Savings in the U.S.